2015 Fiscal Year Final Research Report
The development of a new therapy in diabetic retinopathy by application of alpha-glucosylhesperidin
| Project/Area Number |
25861609
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Ophthalmology
|
|---|
| Research Institution | Asahikawa Medical College |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2013-04-01 – 2016-03-31
|
| Keywords | 糖尿病網膜症 / 虚血性網膜症 / 神経保護 / 血管保護 / 分散ヘスペレチン / 糖転移ヘスペリジン |
|---|
| Outline of Final Research Achievements |
The present study for the first time demonstrated that water-dispersible hesperetin (WD-Hpt) decreased the number of cell death in the ganglion cell layer after ischemia reperfusion (I/R) injury in the retina. This beneficial protective effect of WD-Hpt on the retina derived from reduction of oxidative stress. Consequently, this led to alleviation of activated microglia and reduction of chronic inflammation. Therefore, WD-Hpt is likely to protect neural cells in the retina from diabetes by reducing oxidative stress and chronic inflammation. Moreover, WD-Hpt was shown to reduce I/R-induced gliosis in Muller cells. This also indicates that WD-Hpt can be used for the treatment in diabetic macular edema.
|
| Free Research Field |
眼科学
|
